Mesoblast

Mesoblast begins subject enrolment in Phase III back pain treatment trial
Clinical Trials Arena
Mon, 07/22/24 - 11:31 am
Mesoblast
clinical trials
back pain
rexlemestrocel-L
Mesoblast Sees Path Forward for Twice-Rejected Cell Therapy After FDA Meeting
BioSpace
Thu, 09/21/23 - 10:38 am
Mesoblast
remestemcel-L
FDA
graft vs host disease
Mesoblast's CEO takes 30% pay cut to fund 3rd shot at cell therapy approval
Fierce Biotech
Thu, 08/31/23 - 10:13 am
Mesoblast
cell therapy
FDA
Pharma CEOs
executive compensation
FDA Decisions 2023: Sandoz, Gilead Sciences and More
BioSpace
Fri, 08/25/23 - 11:31 am
FDA
Sandoz
Novartis
Gilead Sciences
Pfizer
Neurocrine
Regeneron
Ipsen
Revance Therapeutics
Delcath Systems
Janssen
Galera Therapeutics
Biogen
Roche
Mesoblast
Taiho Oncology
FDA Blocks Mesoblast Cell Therapy Again, Asks for More Data
BioSpace
Sun, 08/6/23 - 09:34 pm
Mesoblast
remestemcel-L
FDA
graft vs host disease
cell therapy
FDA rejects Mesoblast's cell therapy for bone marrow transplant complications
Yahoo/Reuters
Fri, 08/4/23 - 12:07 pm
Mesoblast
FDA
cell therapy
bone marrow transplants
remestemcel-L
FDA Action Alert: Mesoblast, Sage/Biogen and Galera
BioSpace
Mon, 07/31/23 - 10:05 am
FDA
graft vs host disease
head and neck cancer
postpartum depression
major depressive disorder
Mesoblast
remestemcel-L
Biogen
SAGE Therapeutics
zuranolone
Galera Therapeutics
avasopasem manganese
2 years after rejection, Mesoblast touts long-term cell therapy survival data as key to FDA resubmission
Fierce Biotech
Sun, 11/27/22 - 07:05 pm
Mesoblast
FDA
cell therapy
remestemcel-L
graft vs host disease
Mesoblast considers plans for COVID treatment after Novartis exits deal
Biopharma Reporter
Mon, 12/20/21 - 10:48 am
Mesoblast
Novartis
clinical trials
COVID-19
Mesoblast pummelled as Novartis exits COVID deal
Pharmaforum
Tue, 12/14/21 - 10:42 am
Novartis
Mesoblast
stem cells
remestemcel-L
COVID-19
New Mesoblast Data Offers Hope for High-Risk Heart Patients
BioSpace
Mon, 12/6/21 - 10:54 am
Mesoblast
rexlemestrocel-L
chronic heart failure
clinical trials
Mesoblast’s COVID-19 Respiratory Therapy Hits Another Snag on Route to Potential EUA
BioSpace
Thu, 09/2/21 - 09:16 am
Mesoblast
COVID-19
Emergency Use Authorization
respiratory therapy
Mesoblast shares plunge 32% after stem-cell therapy not likely to meet target for reducing mortality due to COVID-19
Seeking Alpha
Fri, 12/18/20 - 10:57 am
Mesoblast
clinical trials
remestemcel-L
COVID-19
Mesoblast spins a PhIII cell therapy miss in heart failure as a win, highlighting positive mortality data
Endpoints
Tue, 12/15/20 - 08:22 pm
Mesoblast
FDA
clinical trials
rexlemestrocel-L
Novartis Inks $1.35 Billion Deal with Mesoblast for Remestemcel-L for COVID-19 ARDS
BioSpace
Fri, 11/20/20 - 11:08 am
Novartis
Mesoblast
remestemcel-L
COVID-19
ARDS
clinical trials
Mesoblast hit by FDA rejection, request to run another trial
Fierce Biotech
Fri, 10/2/20 - 12:38 pm
Mesoblast
cell therapy
clinical trials
remestemcel-L
graft vs host disease
FDA
Go or no go? A quiet month ahead for US approval verdicts
EP Vantage
Fri, 08/28/20 - 10:29 am
FDA
Bristol-Myers Squibb
CC-486
AML
Mallinckrodt
terlipressin
Mesoblast
Ryoncil
Mesoblast scores FDA committee's backing for cell therapy despite some early worries
Fierce Pharma
Fri, 08/14/20 - 12:45 pm
Mesoblast
cell therapy
FDA
Ryoncil
graft vs host disease
Mesoblast faces FDA pushback over cell therapy manufacturing, clinical data: documents
Fierce Pharma
Wed, 08/12/20 - 10:56 am
Mesoblast
FDA
cell therapy
drug manufacturing
Clinical Trials Of Mesoblast’s Stem Cell Treatment For COVID-19 Set To Begin Soon
Forbes
Sat, 05/2/20 - 11:16 pm
Mesoblast
Australia
clinical gtrials
ARDS
COVID-19
stem cells
remestemcel-L

Pages